P4HA2 and breast neoplasm: Furthermore, deletions of chromosome regions harboring GPM6 (4q34.2), CASP3 (4q35.1), and P4HA2 (5q23.3) have been shown to be associated with breast tumors from BRCA1 mutation carriers [29]–[31],[18].